Insulin-like Growth Factor Receptor as a Therapeutic Target in Head and Neck CancerChristopher J. Barnes, Rakesh Kumar(GlaxoSmithKline (United States))Clinical Cancer ResearchJuly 15, 200710.1158/1078-0432.ccr-06-2040Cited by 141SaveCiteExport RISWatch citationsRelated PapersAKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines|Blood|2008|165WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma|PLoS ONE|2015|67